Atlas Trials

Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy

Clinical trial NCT02371161 · UNKNOWN

Trial details

NCT number
NCT02371161
Sponsor
Fondazione Italiana Linfomi - ETS
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non Hodgkin Lymphoma
Start date
2014-02-01
Primary completion
2018-12-01
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.